// App-Quantinova.ai

276 : Prognostic value of tumor size varies by treatment in a meta-analysis of 15 randomized clinical trials in advanced non-small cell lung cancer across immunotherapy, TKI, and chemotherapy regimens

Researchers

Presenter

  • Jacqueline Buros

Principal Investigators

  • Krzysztof Sakrejda

  • Daniel Lee

  • Eric Novik

  • Philip Jewsbury

Medical Centers

  • Generable, Inc., Brooklyn, NY, USA

  • AstraZeneca, Cambridge, MA

Locations

  • United States

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved